Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2010 1
2012 1
2017 2
2018 1
2019 2
2020 3
2021 2
2022 1
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Jhund PS, Belohlavek J, Chiang CE, Borleffs CJW, Comin-Colet J, Dobreanu D, Drozdz J, Fang JC, Alcocer-Gamba MA, Al Habeeb W, Han Y, Cabrera Honorio JW, Janssens SP, Katova T, Kitakaze M, Merkely B, O'Meara E, Saraiva JFK, Tereshchenko SN, Thierer J, Vaduganathan M, Vardeny O, Verma S, Pham VN, Wilderäng U, Zaozerska N, Bachus E, Lindholm D, Petersson M, Langkilde AM; DELIVER Trial Committees and Investigators. Solomon SD, et al. N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286. Epub 2022 Aug 27. N Engl J Med. 2022. PMID: 36027570 Clinical Trial.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Li J, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Varin C, Honarpour N, Abbasi SA, Malik FI, Kurtz CE; GALACTIC-HF Investigators. Teerlink JR, et al. N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33185990 Clinical Trial.
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L; Gore REDUCE Clinical Study Investigators. Søndergaard L, et al. N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi: 10.1056/NEJMoa1707404. N Engl J Med. 2017. PMID: 28902580 Free article. Clinical Trial.
Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease.
Akhiyat N, Lasho T, Ganji M, Toya T, Shi CX, Chen X, Braggio E, Ahmad A, Corban MT, Stewart K, Fernandez J, Xie Z, Finke C, Lerman LO, Patnaik MM, Lerman A. Akhiyat N, et al. Arterioscler Thromb Vasc Biol. 2023 May;43(5):774-783. doi: 10.1161/ATVBAHA.122.318928. Epub 2023 Mar 23. Arterioscler Thromb Vasc Biol. 2023. PMID: 36951061 Free article.
Evaluation of AGM and FEM method for thermal radiation on nanofluid flow between two tubes in nearness of magnetism field.
Alizadeh A, Shahabi Takami SF, Iranmanesh R, Pasha P. Alizadeh A, et al. Heliyon. 2023 May 30;9(6):e16788. doi: 10.1016/j.heliyon.2023.e16788. eCollection 2023 Jun. Heliyon. 2023. PMID: 37303552 Free PMC article.
The novelty of this study is examining convective heat transfer for nanofluid flow between two flat tubes with the Akbari-Ganji method and Finite Element Techniques to examine the heat flux field by implies of 2D forms of temperature and velocity at unprecedented Reynolds …
The novelty of this study is examining convective heat transfer for nanofluid flow between two flat tubes with the Akbari-Ganji metho …
J-Difference editing (MEGA) of lactate in the human brain at 3T.
Robison RK, Haynes JR, Ganji SK, Nockowski CP, Kovacs Z, Pham W, Morgan VL, Smith SA, Thompson RC, Omary RA, Gore JC, Choi C. Robison RK, et al. Magn Reson Med. 2023 Sep;90(3):852-862. doi: 10.1002/mrm.29693. Epub 2023 May 8. Magn Reson Med. 2023. PMID: 37154389 Free PMC article.
Prevalence and epidemiological investigation of mgrB-dependent colistin resistance in extensively drug resistant Klebsiella pneumoniae in Iran.
Zahedi Bialvaei A, Eslami P, Ganji L, Dolatyar Dehkharghani A, Asgari F, Koupahi H, Barzegarian Pashacolaei HR, Rahbar M. Zahedi Bialvaei A, et al. Sci Rep. 2023 Jul 1;13(1):10680. doi: 10.1038/s41598-023-37845-z. Sci Rep. 2023. PMID: 37393362 Free PMC article.
Carbapenemases-producing K. pneumoniae are challenging antimicrobial therapy of hospitalised patients, which is further complicated by colistin resistance. The aim of this study was to investigate the molecular epidemiological insights into carbapenemases-producing and col …
Carbapenemases-producing K. pneumoniae are challenging antimicrobial therapy of hospitalised patients, which is further complicated b …
Designing a new dimerized anti human TNF-α aptamer with blocking activity.
Mashayekhi K, Ganji A, Sankian M. Mashayekhi K, et al. Biotechnol Prog. 2020 Jul;36(4):e2969. doi: 10.1002/btpr.2969. Epub 2020 Mar 10. Biotechnol Prog. 2020. PMID: 31989789
The truncation and dimerization strategy revealed a new dimer aptamer with 67 nM K(d) , which has 40% inhibitory effect compared with Etanercept (60%). ...
The truncation and dimerization strategy revealed a new dimer aptamer with 67 nM K(d) , which has 40% inhibitory effect compared with …
18 results